What Nanoimmunotech does

Nanoimmunotech (operating as Nano Immuno Tech) is a European private biotechnology company founded in 2009 that specializes in the synthesis and functionalization of nanoparticles and their application in biosensing, anchored by its proprietary HEATSENS technology. According to the firmographic record, the company was founded in Zaragoza, Spain, while its operational presence, website, and contact infrastructure are based in Berlin, Germany, suggesting a cross-border European footprint. The company employs 11-50 staff and operates in the nanobiotechnology and DNA technology space, with stated capabilities spanning nanoparticle manipulation, targeted drug delivery, CRISPR-Cas9 gene editing, synthetic biology, and DNA analysis and diagnostics.

The company's offering is structured around a core Nano Immuno Tech Platform supplemented by product modules for diagnostic tools, DNA analysis services, and nanomedicine development, with professional consulting and custom research services layered on top. Its technology stack is built on nanoparticle manipulation at the nanometer scale, genome sequencing technologies, and CRISPR-Cas9 tools, positioning the company to serve biotechnology and healthcare customers requiring specialized R&D support. The business model is project-based: revenue is generated through custom biotechnology solutions (professional services) and one-time licensing of nanomedicine and diagnostic products, with pricing conducted via direct contact-based quotation rather than disclosed rates.

The go-to-market is sales-led and B2B, relying on content marketing through the website and blog, organic search, direct email ([email protected]), and phone-based consultation to engage enterprise and SMB biotech customers globally. The company claims global reach and reports customer outcomes of a 25% retention increase and 1.7X user base growth, though these figures are self-reported and not externally validated. The only disclosed capital event is a ~$1.48 million grant from EISMEA in 2016, and there is no reported revenue, no disclosed patents or trademarks, no management team bios, and no known partnerships, leaving significant gaps in verifiable commercial evidence.

Name

Nanoimmunotech

Legal name

Nano Immuno Tech

Website

https://nanoimmunotech.eu

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Nanoimmunotech (Nano Immuno Tech) is a European private nanobiotechnology company founded in 2009 that develops nanoparticle-based biosensing (HEATSENS), CRISPR-Cas9 tools, nanomedicines, and DNA diagnostics for biotech and healthcare customers worldwide.

Ownership category

akta.pro rank

Product category

Nanobiotechnology Research and Development Services

NAICS

Research and Development in Nanotechnology (541713), Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods) (HLAAABAL)

akta.pro secondary industries

Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

• Nanobiotechnology services
• DNA analysis solutions
• Nanomedicine development
• Diagnostic biosensors
• Biotech consulting

Headquarters

HQ city

Zaragoza

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Custom Biotechnology Solutions: Development of tailored nanobiotechnology and DNA technology solutions for clients worldwide. Services include research and development, consulting, and customized biotechnological products.
2. Nanomedicine Products: Development and provision of nanomedicines and diagnosis tools for healthcare applications.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Nanoimmunotech develops customized nanobiotechnology and DNA technology solutions for biotech companies and the healthcare sector. Its offerings include the proprietary HEATSENS biosensing platform based on nanoparticle synthesis and functionalization, nanomedicine development, diagnostic tools, DNA analysis and genome sequencing services, CRISPR-Cas9 based gene editing, and tailored consulting/research services delivered globally with implementation support and training.

Product overview

Nano Immuno Tech offers a unified platform for global nanobiotechnology and DNA technology solutions. The core offering combines the main Nano Immuno Tech Platform with specialized product modules including Diagnostic Tools, DNA Analysis Services, and Nanomedicine Development. Additional services include consulting and research services from expert teams. The company provides comprehensive support from implementation to training, with customized solutions tailored to individual customer needs in the biotechnology sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Nanobiotechnology and DNA Technology Solutions Tailored nanobiotechnology and DNA technology solutions for biotech companies worldwide, including nanoparticle synthesis, biosensing, and synthetic biology applications.
• HEATSENS Biosensing Platform Biosensing platform leveraging nanoparticle synthesis and functionalization for detection applications in medical and biotechnology use cases.
• Nanomedicine Development Services Development of nano-based medicines and targeted drug delivery applications for the healthcare industry using proprietary nanotechnology.
• Diagnostic Tools Development Advanced diagnostic tools developed using nanobiotechnology for medical and biotechnology diagnostic applications.
• DNA Analysis and Genome Sequencing Services DNA analysis and genome sequencing technologies applied to biotechnology research, diagnostics, and custom client projects.
• Biotechnology Consulting and Custom Research Expert-led consulting and customized research services delivered to biotech and healthcare clients, including implementation support and user training.

Quantifiable outcome

• 25% increase in retention for customers using their solutions
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• Oxford Nanopore Technologies: Commercialises nanopore-based DNA/RNA sequencing platforms. Directly comparable to Nanoimmunotech's combination of nanoparticle technology, DNA analysis services, and biosensing.
• GenScript: Global life-science services and product company offering gene synthesis, CRISPR reagents, and custom biotech solutions. Closely aligned to Nanoimmunotech's custom biotechnology solutions and DNA analysis services.
• NanoString Technologies (Bruker): Develops nano-enabled molecular profiling/diagnostic tools and biosensing platforms. Comparable core technology (nanoparticle-based biosensing) and end-customers in research and clinical diagnostics.
• Selecta Biosciences: Clinical-stage biotech developing nanoparticle immunotherapies and targeted drug delivery using proprietary nanocarriers. Directly comparable use of nanoparticles for therapeutic applications.
• CD Genomics: Provides genomics, DNA sequencing, and DNA analysis services globally. Directly comparable to Nanoimmunotech's DNA Analysis Services and Diagnostic Tools modules.
• Starpharma Holdings: Develops dendrimer nanoparticle drug-delivery and diagnostics products. Closely comparable to Nanoimmunotech's nanoparticle-based targeted drug delivery and biosensing applications.

Broad incumbents

• Eurofins Scientific: Large global CRO providing genomics, biopharma services, and diagnostic testing. Overlaps with Nanoimmunotech's custom biotech R&D and DNA analysis services across a much broader portfolio.
• Bio-Rad Laboratories: Established life-science tools and clinical diagnostics company with biosensor/reagent offerings and a global footprint. Overlaps with Nanoimmunotech's diagnostic tools and biosensing (HEATSENS) activities.

Emerging players

• Twist Bioscience: High-throughput DNA synthesis and NGS-based products serving biotech customers. Compares on the synthetic biology / DNA technology axis and as a custom biotech solutions provider.

Regional players

• BGI Genomics: China-based global provider of DNA sequencing, genomic services, and diagnostics. Comparable in DNA analysis and diagnostic-tools services, with a strong regional footprint differing from Nanoimmunotech's Europe-centric HQ.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/nanoimmunotech

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanoimmunotech